These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 3630201)
1. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats. Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201 [TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
3. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolism of amosulalol hydrochloride, a new combined alpha- and beta-adrenoceptor blocking agent, in rats, dogs and monkeys. Sasaki H; Kamimura H; Kaniwa H; Kawamura S; Takaichi M; Yokoshima T Xenobiotica; 1984 Aug; 14(8):621-31. PubMed ID: 6149657 [TBL] [Abstract][Full Text] [Related]
5. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
8. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of indeloxazine hydrochloride: alpha-glucoside formation in rats. Kamimura H; Kawai R; Kudo H Xenobiotica; 1988 Feb; 18(2):141-9. PubMed ID: 3287777 [TBL] [Abstract][Full Text] [Related]
10. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats. Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
14. [Studies on the biotransformation of fominoben-HCl in man (author's transl)]. Zimmer A; Krüger G; Prox A; Stahl E; Wolter B; Wachsmuth H; Köster P Arzneimittelforschung; 1978; 28(4):688-92. PubMed ID: 155457 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol. Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533 [TBL] [Abstract][Full Text] [Related]
16. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog. Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226 [TBL] [Abstract][Full Text] [Related]
18. Metabolism and disposition of moxonidine in Fischer 344 rats. He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314 [TBL] [Abstract][Full Text] [Related]
19. Disposition and metabolism of [14C]-amezinium metilsulfate in rats. Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436 [TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]